Drugs / SYNB1020
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT03179878 | Jun → Nov 2017 | urea cycle disorder | Synlogic | Completed | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT03447730 | Mar 2018 → Jul 2019 | cirrhosis of liver | Synlogic | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SYNB1020 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03179878 ↗ |
| Route | Oral | “administered orally” NCT03447730 ↗ |